Intravascular Ultrasound Assessment of In-Stent Restenosis in Saphenous Vein Grafts.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
01 04 2019
Historique:
received: 30 11 2018
revised: 12 12 2018
accepted: 19 12 2018
pubmed: 16 1 2019
medline: 10 1 2020
entrez: 16 1 2019
Statut: ppublish

Résumé

Outcomes after percutaneous coronary interventions (PCI) in saphenous vein grafts (SVG) are inferior compared with native coronary arteries, but the mechanisms of SVG in-stent restenosis (ISR) have not been well-described. Thus, we aimed to evaluate the patterns of SVG ISR using intravascular ultrasound (IVUS) in 54 SVG ISR lesions. Stent underexpansion was defined as minimum stent area (MSA) <5 mm

Identifiants

pubmed: 30642605
pii: S0002-9149(19)30033-5
doi: 10.1016/j.amjcard.2018.12.030
pii:
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1052-1059

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Rafal Wolny (R)

Institute of Cardiology, Warsaw, Poland; Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Division of Cardiology, Department of Medicine, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York.

Gary S Mintz (GS)

Clinical Trials Center, Cardiovascular Research Foundation, New York, New York.

Mitsuaki Matsumura (M)

Clinical Trials Center, Cardiovascular Research Foundation, New York, New York.

Masaru Ishida (M)

Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Division of Cardiology, Department of Medicine, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York.

Yuqi Fan (Y)

Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Division of Cardiology, Department of Medicine, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York; Department of Cardiology, Shanghai 9th People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.

Khady N Fall (KN)

Division of Cardiology, Department of Medicine, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York.

Manish A Parikh (MA)

Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Division of Cardiology, Department of Medicine, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York.

LeRoy E Rabbani (LE)

Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Division of Cardiology, Department of Medicine, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York.

Ziad A Ali (ZA)

Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Division of Cardiology, Department of Medicine, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York.

Dimitri Karmpaliotis (D)

Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Division of Cardiology, Department of Medicine, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York.

Ajay J Kirtane (AJ)

Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Division of Cardiology, Department of Medicine, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York.

Jeffrey W Moses (JW)

Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Division of Cardiology, Department of Medicine, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York; St. Francis Hospital, Roslyn, New York.

Akiko Maehara (A)

Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Division of Cardiology, Department of Medicine, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York. Electronic address: amaehara@crf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH